Insights
Insights From Our Experts
Articles
How Can Utilizing Digital Therapeutics Provide Better Care to the Veteran Population?
EVERSANA’s Joe Perekupka, Chief Commercial Officer, participated in a keynote panel discussion at the recent DTx West Summit: “How Can Utilizing Digital Therapeutics Provide Better Care to the Veteran Population?” Joe was joined by moderator Debra…
Prescription Digital Therapeutics Coding: A Good First Step by CMS
The Centers for Medicare and Medicaid Services (CMS) recently issued a new code under the Healthcare Common Procedural Coding System (HCPCS) regarding prescription digital therapeutics (PDTs). These types of therapies are generally app- or device-based and…
Understanding Current Trends and Needs: Medical Information Contact Center Services
“Understanding Current Trends and Needs: Medical Information Contact Center Services,” a poster by EVERSANA’s Michael DeLuca, Senior Vice President, Medical Affairs, and Keyur Brahmbhatt, Director, Medical Affairs, along with Evelyn Hermes-DeSantis, Director, Research and Publications, phactMI,…
Succeed When Others Fail: Avoiding 20% in Investment Waste During Launch
It’s a long-standing perception that pharma overspends during launch, but we did not have the data or methodology to understand or validate this notion. Until now. New Research by the Numbers 10: Recent analysis across 10…
THINK BEYOND THE THERAPY: Demystifying the Complexities of Cell and Gene Therapy Commercialization
While much attention has been given to the novel science behind cell and gene therapies, ultimately the success of every precision medicine starts and ends with the patient. Whether coordinating a cell or gene therapy clinical…
Importance of Impactful Medical Information Content
Medical Information (MI) services have evolved as technology has advanced and healthcare professionals’ and patients’ needs and preferences have changed. Understanding the audience, identifying the most beneficial content format, and utilizing the preferred channels of communication…
WEBINAR: Innovative Pharmacy and Distribution Models Driven by Market Dynamics, Product Type, Site of Care and Reimbursement
The landscape of the pharmaceutical distribution industry is shifting from a familiar state to a novel market calling for a new level of channel service due to forces of innovation. In this webinar, EVERSANA’s Scot Buchanan,…
How to Ensure Speed and Efficiency When Launching in Europe
Today is an extraordinary time for medical innovation. The pharmaceutical industry is yielding protection against diseases, focusing more on rare and complex disease treatments, and the world is getting better health outcomes. Global life expectancy is…
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
As physicians, patients and caregivers tirelessly fight complex diseases, a growing number of drug manufacturers are preparing to launch new oncology therapies. These high-science therapies are entering the market at rapid rates: Presently, there are 500…
A Holistic Launch in Europe Is Possible, But Change Is Necessary
Unless you live in Europe or have commercialized a product in this region, you may not realize that the European pharmaceutical market is a huge contributor to global health, and it is currently undergoing market-wide changes.…